This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hill, R. Articles by Van Dyke, T. Search for Related Content PubMed PubMed Citation Articles by Hill, R. Articles by Van Dyke, T.

Heterogeneous Tumor Evolution Initiated by Loss of pRb Function in a Preclinical Prostate Cancer Model

¹ Curriculum in Genetics and Molecular Biology and ² Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and ³ Center for Comparative Medicine, University of California at Davis, Davis, California

Requests for reprints: Terry Van Dyke, Genetics Department, University of North Carolina at Chapel Hill, Chapel Hill, NC. Phone: 919-962-2145; E-mail: tvdlab{at}med.unc.edu.

Because each change in the evolution of a cancer is predicated on the effects of previous events, a full understanding of selective changes and their effect on tumor progression can only be understood in the context of appropriate initiating events. Here, we define the effect of pRb function inactivation in prostate epithelium on both the initiation of prostate cancer and the establishment of selective pressures that lead to diminished Pten function and tumor evolution. Using genetically engineered mice, we show that inactivation of the pRb family proteins (Rb/p107/p130) induces epithelial proliferation and apoptosis and is sufficient to produce prostatic intraepithelial neoplasia (PIN) lesions. Over time, adenocarcinomas develop in all mice with no evidence of neuroendocrine tumors. Apoptosis is dependent on Pten function and not p53, unlike other epithelial cell types tested previously. Consequently, Pten hemizygosity reduces apoptosis by 50%, accelerating progression to adenocarcinomas with heterogeneous composition. Heterogeneity is associated with concurrent Pten haploinsufficiency and focal selective progression to complete Pten loss, which yields distinct tumor properties. Given that this analysis models the apparent timing of highly penetrant events in human prostate cancer, observed effects may recapitulate the natural evolution of prostate cancer development.

This article has been cited by other articles:

				S. Akakura, C. Huang, P. J. Nelson, B. Foster, and I. H. Gelman Loss of the ssecks/gravin/akap12 Gene Results in Prostatic Hyperplasia Cancer Res., July 1, 2008; 68(13): 5096 - 5103. [Abstract] [Full Text] [PDF]

				X. Lu, C. Yang, R. Hill, C. Yin, M. C. Hollander, A. J. Fornace Jr, and T. Van Dyke Inactivation of gadd45a Sensitizes Epithelial Cancer Cells to Ionizing Radiation In vivo Resulting in Prolonged Survival Cancer Res., May 15, 2008; 68(10): 3579 - 3583. [Abstract] [Full Text] [PDF]

				M. T. Saenz-Robles, J. A. Markovics, J.-L. Chong, R. Opavsky, R. H. Whitehead, G. Leone, and J. M. Pipas Intestinal Hyperplasia Induced by Simian Virus 40 Large Tumor Antigen Requires E2F2 J. Virol., December 1, 2007; 81(23): 13191 - 13199. [Abstract] [Full Text] [PDF]

				A. Sharma, C. E.S. Comstock, E. S. Knudsen, K. H. Cao, J. K. Hess-Wilson, L. M. Morey, J. Barrera, and K. E. Knudsen Retinoblastoma Tumor Suppressor Status Is a Critical Determinant of Therapeutic Response in Prostate Cancer Cells Cancer Res., July 1, 2007; 67(13): 6192 - 6203. [Abstract] [Full Text] [PDF]

				C. J Burd, L. M Morey, and K. E Knudsen Androgen receptor corepressors and prostate cancer Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994. [Abstract] [Full Text] [PDF]

				C. W. Menges, L. A. Baglia, R. Lapoint, and D. J. McCance Human Papillomavirus Type 16 E7 Up-regulates AKT Activity through the Retinoblastoma Protein Cancer Res., June 1, 2006; 66(11): 5555 - 5559. [Abstract] [Full Text] [PDF]

				K. SIMIN, R. HILL, Y. SONG, Q. ZHANG, R. BASH, R.D. CARDIFF, C. YIN, A. XIAO, K. McCARTHY, and T. V. DYKE Deciphering Cancer Complexities in Genetically Engineered Mice Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 283 - 290. [Abstract] [PDF]